Biotest GmbH & Co. KGaA (HAM:BIO0)
33.00
0.00 (0.00%)
At close: Jul 2, 2026
Biotest GmbH & Co. KGaA Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 89.8 | 107.8 | 108.1 | 116.6 | 104.4 |
Short-Term Investments | - | - | 10.4 | 12.4 | 8.7 |
Cash & Short-Term Investments | 89.8 | 107.8 | 118.5 | 129 | 113.1 |
Cash Growth | -16.70% | -9.03% | -8.14% | 14.06% | 35.29% |
Accounts Receivable | 220.2 | 193.9 | 196.8 | 159.7 | 146.4 |
Other Receivables | 8 | 12.8 | 10 | 20.2 | 8.6 |
Receivables | 228.2 | 206.7 | 206.8 | 179.9 | 155 |
Inventory | 530.7 | 479.5 | 419.1 | 293.8 | 244.6 |
Prepaid Expenses | - | - | - | - | 5.8 |
Other Current Assets | 25.1 | 15.5 | 12.1 | 16.7 | 3.7 |
Total Current Assets | 873.8 | 809.5 | 756.5 | 619.4 | 522.2 |
Property, Plant & Equipment | 488.3 | 485.3 | 475.7 | 460.3 | 476.7 |
Long-Term Investments | 35.1 | 2.1 | 11.3 | 5.1 | 4.6 |
Goodwill | 6 | 6 | 6 | 7.2 | 7.1 |
Other Intangible Assets | 1.8 | 1.7 | 2.1 | 2.4 | 3.3 |
Long-Term Deferred Tax Assets | 42.9 | 19.5 | 32.9 | 0.7 | 10.2 |
Long-Term Deferred Charges | 6.4 | 3.9 | 1 | 0.5 | - |
Other Long-Term Assets | 70.2 | 90.7 | 108.8 | 94.3 | 74.6 |
Total Assets | 1,530 | 1,434 | 1,411 | 1,203 | 1,104 |
Accounts Payable | 78.2 | 88.4 | 78.1 | 51.1 | 38.8 |
Accrued Expenses | 6.1 | 5.6 | 7.6 | 6.8 | 9.5 |
Current Portion of Long-Term Debt | 19.5 | 30.4 | 254.7 | 26.7 | 30 |
Current Portion of Leases | 6 | 5.5 | 5.4 | 4.6 | 4.8 |
Current Income Taxes Payable | 2.2 | 1.1 | 0.9 | 0.3 | 0.5 |
Current Unearned Revenue | 17.8 | 4.4 | 2.9 | 2.9 | 2.1 |
Other Current Liabilities | 25.5 | 24.7 | 35.7 | 37.8 | 20.7 |
Total Current Liabilities | 155.3 | 160.1 | 385.3 | 130.2 | 106.4 |
Long-Term Debt | 753.3 | 582.9 | 377.3 | 588.4 | 474.4 |
Long-Term Leases | 52.8 | 53 | 52.4 | 24.4 | 22 |
Pension & Post-Retirement Benefits | 87.9 | 91.7 | 91.1 | 85.8 | 116.5 |
Long-Term Deferred Tax Liabilities | 1.1 | 1.1 | 1.1 | 1.2 | 2.2 |
Other Long-Term Liabilities | 15.8 | 14.5 | 4.8 | 1.9 | 2.3 |
Total Liabilities | 1,066 | 903.3 | 912 | 831.9 | 723.8 |
Common Stock | 39.6 | 39.6 | 39.6 | 39.6 | 39.6 |
Additional Paid-In Capital | 219.8 | 219.8 | 219.8 | 219.8 | 219.8 |
Retained Earnings | 203 | 274.5 | 249.8 | 113.7 | 123 |
Comprehensive Income & Other | 1.1 | -3.2 | -10.3 | -2 | -2 |
Total Common Equity | 463.5 | 530.7 | 498.9 | 371.1 | 380.4 |
Shareholders' Equity | 463.5 | 530.7 | 498.9 | 371.1 | 380.4 |
Total Liabilities & Equity | 1,530 | 1,434 | 1,411 | 1,203 | 1,104 |
Total Debt | 831.6 | 671.8 | 689.8 | 644.1 | 531.2 |
Net Cash (Debt) | -741.8 | -564 | -571.3 | -515.1 | -418.1 |
Net Cash Per Share | -18.75 | -14.25 | -14.44 | -13.02 | -10.57 |
Filing Date Shares Outstanding | 39.57 | 39.57 | 39.57 | 39.57 | 39.57 |
Total Common Shares Outstanding | 39.57 | 39.57 | 39.57 | 39.57 | 39.57 |
Working Capital | 718.5 | 649.4 | 371.2 | 489.2 | 415.8 |
Book Value Per Share | 11.71 | 13.41 | 12.61 | 9.38 | 9.61 |
Tangible Book Value | 455.7 | 523 | 490.8 | 361.5 | 370 |
Tangible Book Value Per Share | 11.52 | 13.22 | 12.40 | 9.14 | 9.35 |
Land | 329 | 324 | 322.6 | 318 | 315.9 |
Machinery | 399.6 | 375 | 339.1 | 335.6 | 443.9 |
Order Backlog | 68.3 | 68.2 | 110.2 | 98.8 | 53.9 |